1. Emotional changes in men treated with sildenafil citrate for erectile dysfunction: a double-blind, placebo-controlled clinical trial.
- Author
-
Moncada I, Martínez-Jabaloyas JM, Rodriguez-Vela L, Gutiérrez PR, Giuliano F, Koskimaki J, Farmer IS, Renedo VP, and Schnetzler G
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Depressive Disorder diagnosis, Depressive Disorder epidemiology, Depressive Disorder psychology, Double-Blind Method, Erectile Dysfunction epidemiology, Humans, Hyperlipidemias epidemiology, Hypertension epidemiology, Male, Middle Aged, Phosphodiesterase 5 Inhibitors, Prostatic Hyperplasia epidemiology, Purines therapeutic use, Quality of Life psychology, Self Concept, Sildenafil Citrate, Surveys and Questionnaires, Young Adult, Erectile Dysfunction drug therapy, Expressed Emotion, Phosphodiesterase Inhibitors therapeutic use, Piperazines therapeutic use, Sulfones therapeutic use
- Abstract
Introduction: Erectile dysfunction (ED) has been associated with several comorbidities and can cause significant loss of quality of life and self-esteem., Aim: In men with ED, to use the validated Self-Esteem and Relationship (SEAR) questionnaire to evaluate changes in self-esteem associated with sildenafil treatment of ED and to assess changes dependent on concomitant comorbid conditions., Methods: This was a 14-week, international, randomized, parallel-group, double-blind, flexible-dose (25, 50, or 100 mg), placebo-controlled study of sildenafil in men aged >or=18 years with a clinical diagnosis of ED (score
- Published
- 2009
- Full Text
- View/download PDF